Feeding filaggrin: effects of l-histidine supplementation in atopic dermatitis

References

• WilliamsHRobertsonCStewartAWorldwide variations in the prevalence of symptoms of atopic eczema in the International Study of Asthma and Allergies in ChildhoodJ Allergy Clin Immunol19991031251389893196
   PubMed Web of Science ®Google Scholar
• RönmarkEPEkerljungLLötvallJEczema among adults: prevalence, risk factors and relation to airway diseases. Results from a large-scale population survey in SwedenBr J Dermatol20121661301130822372948
   PubMed Web of Science ®Google Scholar
• WatsonWKapurSAtopic dermatitisAllergy Asthma Clin Immunol20117Suppl 1S422166055
   PubMedGoogle Scholar
• WeidingerSNovakNAtopic dermatitisLancet20163871109112226377142
   PubMed Web of Science ®Google Scholar
• KatohNFuture perspectives in the treatment of atopic dermatitisJ Dermatol20093636737619583684
   PubMed Web of Science ®Google Scholar
• PalmerCNAIrvineADTerron-KwiatkowskiACommon loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitisNat Genet20063844144616550169
   PubMed Web of Science ®Google Scholar
• BrownSJMcLeanWHIEczema genetics: current state of knowledge and future goalsJ Invest Dermatol129543552
   Web of Science ®Google Scholar
• IrvineADMcLeanWHILeungDYMFilaggrin mutations associated with skin and allergic diseasesN Engl J Med20113651315132721991953
   PubMed Web of Science ®Google Scholar
• VoorheesJJChakrabartiSGBernsteinIAThe metabolism of “histidine-rich” protein in normal and psoriatic keratinizationJ Invest Dermatol1968513443544176648
   PubMed Web of Science ®Google Scholar
• BrownSJMcLeanWHIOne remarkable molecule: filaggrinJ Invest Dermatol201213275176222158554
   PubMed Web of Science ®Google Scholar
• RobertsonEDWeirLRomanowskaMLeighIMPanteleyevAAARNT controls the expression of epidermal differentiation genes through HDAC- and EGFR-dependent pathwaysJ Cell Sci20121253320333222505606
   PubMed Web of Science ®Google Scholar
• LynleyAMDaleBAThe characterization of human epidermal filaggrin. A histidine-rich, keratin filament-aggregating proteinBiochim Biophys Acta198374428356187370
   PubMed Web of Science ®Google Scholar
• GruberREliasPMCrumrineDFilaggrin genotype in ichthyosis vulgaris predicts abnormalities in epidermal structure and functionAm J Pathol20111782252226321514438
   PubMed Web of Science ®Google Scholar
• ScottIRHardingCRBarrettJGHistidine-rich protein of the keratohyalin granules. Source of the free amino acids, urocanic acid and pyrrolidone carboxylic acid in the stratum corneumBiochim Biophys Acta19827191101177171620
   PubMed Web of Science ®Google Scholar
• HosteEKempermanPDevosMCaspase-14 is required for filaggrin degradation to natural moisturizing factors in the skinJ Invest Dermatol20111312233234121654840
   PubMed Web of Science ®Google Scholar
• McAleerMAIrvineADThe multifunctional role of filaggrin in allergic skin diseaseJ Allergy Clin Immunol201313128029123374260
   PubMed Web of Science ®Google Scholar
• BrownSJReltonCLLiaoHFilaggrin null mutations and childhood atopic eczema: a population-based case-control studyJ Allergy Clin Immunol2008121940946.e318313126
   PubMed Web of Science ®Google Scholar
• KezicSO’ReganGMYauNLevels of filaggrin degradation products are influenced by both filaggrin genotype and atopic dermatitis severityAllergy20116693494021261659
   PubMed Web of Science ®Google Scholar
• HowellMDKimBEGaoPCytokine modulation of atopic dermatitis filaggrin skin expressionJ Allergy Clin Immunol2009124R7R1219720210
   PubMed Web of Science ®Google Scholar
• TanSPAbdul-GhaffarSWellerRBBrownSBProtease-antiprotease imbalance may be linked to potential defects in profilaggrin proteolysis in atopic dermatitisBr J Dermatol20121661137114022098374
   PubMed Web of Science ®Google Scholar
• CabanillasBNovakNAtopic dermatitis and filaggrinCurr Opin Immunol2016421827206013
   PubMed Web of Science ®Google Scholar
• OtsukaADoiHEgawaGPossible new therapeutic strategy to regulate atopic dermatitis through upregulating filaggrin expressionJ Allergy Clin Immunol2014133139146e11024055295
   PubMed Web of Science ®Google Scholar
• StoutTEMcFarlandTMitchellJCAppukuttanBStoutJTRecombinant filaggrin is internalized and processed to correct filaggrin deficiencyJ Invest Dermatol201413442342923792461
   PubMed Web of Science ®Google Scholar
• BandoKShimotsujiTToyoshimaHHayashiCMiyaiKFluorometric assay of human serum carnosinase activity in normal children, adults and patients with myopathyAnn Clin Biochem198421Pt 65105146517492
   PubMed Web of Science ®Google Scholar
• KoppleJDSwendseidMEEvidence that histidine is an essential amino acid in normal and chronically uremic manJ Clin Invest1975558818911123426
   PubMed Web of Science ®Google Scholar
• FukuyamaKNakamuraTBensteinIADifferentially localized incorporation of amino acids in relation to epidermal keratinization in the newborn ratAnat Rec19651525255355861516
   PubMedGoogle Scholar
• TanakaMOkadaMZhenYXDecreased hydration state of the stratum corneum and reduced amino acid content of the skin surface in patients with seasonal allergic rhinitisBr J Dermatol19981396186219892905
   PubMed Web of Science ®Google Scholar
• KezicSO’ReganGMYauNLevels of filaggrin degradation products are influenced by both filaggrin genotype and atopic dermatitis severityAllergy20116693494021261659
   PubMed Web of Science ®Google Scholar
• BoukampPPetrussevskaRBreitkreutzDHornungJMarkhamAFusenigNNormal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell lineJ Cell Biol19881067617712450098
   PubMed Web of Science ®Google Scholar
• McMahonAButovichIAKedzierskiWEpidermal expression of an Elovl4 transgene rescues neonatal lethality of homozygous Stargardt disease-3 miceJ Lipid Res2011521128113821429867
   PubMed Web of Science ®Google Scholar
• HerrmannTGröneH-JLangbeinLDisturbed epidermal structure in mice with temporally controlled Fatp4 deficiencyJ Invest Dermatol20051251228123516354193
   PubMed Web of Science ®Google Scholar
• JennemannRSandhoffRLangbeinLIntegrity and barrier function of the epidermis critically depend on glucosylceramide synthesisJ Biol Chem20072823083309417145749
   PubMed Web of Science ®Google Scholar
• EppNFürstenbergerGMüllerK12R-lipoxygenase deficiency disrupts epidermal barrier functionJ Cell Biol200717717318217403930
   PubMed Web of Science ®Google Scholar
• WilliamsHCBurneyPGPembrokeACHayRJThe U.K. Working Party’s Diagnostic Criteria for Atopic Dermatitis. III. Independent hospital validationBr J Dermatol19941314064167918017
   PubMed Web of Science ®Google Scholar
• SchmittJLanganSWilliamsHCWhat are the best outcome measurements for atopic eczema? A systematic reviewJ Allergy Clin Immunol20071201389139817910890
   PubMed Web of Science ®Google Scholar
• WallingHWSwickBLUpdate on the management of chronic eczema: new approaches and emerging treatment optionsClin Cosmet Investig Dermatol2010399
   PubMedGoogle Scholar
• Meth-CohnOBartonDNakanishiKComprehensive Natural Products ChemistryLondonElsevier Science Ltd1999459
   Google Scholar
• KamataYTaniguchiAYamamotoMNeutral cysteine protease bleomycin hydrolase is essential for the breakdown of deiminated filaggrin into amino acidsJ Biol Chem2009284128291283619286660
   PubMed Web of Science ®Google Scholar
• SchoopVMMiranceaNFusenigNEEpidermal organization and differentiation of HaCaT keratinocytes in organotypic coculture with human dermal fibroblastsJ Invest Dermatol199911234335310084313
   PubMed Web of Science ®Google Scholar
• KirkupMEBirchallNMWeinbergEGHelmKKennedyCTCAcute and maintenance treatment of atopic dermatitis in children – two comparative studies with fluticasone propionate (0.05%) creamJ Dermatolog Treat20031414114814522623
   PubMedGoogle Scholar